DocketTrail

LabCorp - BioReference oncology (2025)

CA MA · Latest: CA Notice complete

Agency description

Laboratory Corporation of America Holdings will acquire BioReference’s laboratory testing businesses focused on oncology-related clinical testing services across the United States.

CA Office of Health Care Affordability (HCAI), “Transaction Type” column, hcai.ca.gov

Provider merger/affiliation increasing NPSR $10M

MA Massachusetts Health Policy Commission, “Transaction Type” column, masshpc.gov

State reviews

StateAgencyStatusStageSource
CAOffice of Health Care Affordability (HCAI)CMIR Waived WAIVEDNOTICEAgency record
MAMassachusetts Health Policy CommissionNo NO_CMIRNOTICEAgency record

Trail

Dates as published by the agency unless marked.

  1. MA Notice received
    Date HPC Received: March 19, 2025
  2. CA Notice complete
    Date Submission Completed: May 8, 2025

Not dated

  1. CA Cost and market impact review waived
    CMIR Waived

Changes

Feed

No changes observed since the initial load (CA · MA ).

About the digest

Parties as filed

Documents (3)
Evidence

Grouped by DocketTrail's reviewed seed list, entry labcorp-bioreference-oncology-2025.

Names as filed and source keys

StateTitle as printedSource keyKey method
CALaboratory Corporation of America Holdingsmaterial-change-transaction-notice-labcorp-1365FIRST_DOCUMENT_SLUG
MABioReference Health, LLC / Laboratory Corporation of America Holdings, Inc./sites/default/files/2025-03/20250325_Bioreference-Labcorp_MCN.pdfFIRST_DOCUMENT_PATH

Observed by DocketTrail

StateSource keyFirst seen by DocketTrail (UTC)Last checked (UTC)Page checked
CAmaterial-change-transaction-notice-labcorp-1365hcai.ca.gov
MA/sites/default/files/2025-03/20250325_Bioreference-Labcorp_MCN.pdfmasshpc.gov

Captures